742 related articles for article (PubMed ID: 33676593)
1. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM;
Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593
[TBL] [Abstract][Full Text] [Related]
2. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.
Schultze A; Walker AJ; MacKenna B; Morton CE; Bhaskaran K; Brown JP; Rentsch CT; Williamson E; Drysdale H; Croker R; Bacon S; Hulme W; Bates C; Curtis HJ; Mehrkar A; Evans D; Inglesby P; Cockburn J; McDonald HI; Tomlinson L; Mathur R; Wing K; Wong AYS; Forbes H; Parry J; Hester F; Harper S; Evans SJW; Quint J; Smeeth L; Douglas IJ; Goldacre B;
Lancet Respir Med; 2020 Nov; 8(11):1106-1120. PubMed ID: 32979987
[TBL] [Abstract][Full Text] [Related]
3. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
Russell CD; Fairfield CJ; Drake TM; Turtle L; Seaton RA; Wootton DG; Sigfrid L; Harrison EM; Docherty AB; de Silva TI; Egan C; Pius R; Hardwick HE; Merson L; Girvan M; Dunning J; Nguyen-Van-Tam JS; Openshaw PJM; Baillie JK; Semple MG; Ho A;
Lancet Microbe; 2021 Aug; 2(8):e354-e365. PubMed ID: 34100002
[TBL] [Abstract][Full Text] [Related]
4. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
[TBL] [Abstract][Full Text] [Related]
5. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK.
Docherty AB; Mulholland RH; Lone NI; Cheyne CP; De Angelis D; Diaz-Ordaz K; Donegan C; Drake TM; Dunning J; Funk S; García-Fiñana M; Girvan M; Hardwick HE; Harrison J; Ho A; Hughes DM; Keogh RH; Kirwan PD; Leeming G; Nguyen Van-Tam JS; Pius R; Russell CD; Spencer RG; Tom BD; Turtle L; Openshaw PJ; Baillie JK; Harrison EM; Semple MG;
Lancet Respir Med; 2021 Jul; 9(7):773-785. PubMed ID: 34000238
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
Drake TM; Riad AM; Fairfield CJ; Egan C; Knight SR; Pius R; Hardwick HE; Norman L; Shaw CA; McLean KA; Thompson AAR; Ho A; Swann OV; Sullivan M; Soares F; Holden KA; Merson L; Plotkin D; Sigfrid L; de Silva TI; Girvan M; Jackson C; Russell CD; Dunning J; Solomon T; Carson G; Olliaro P; Nguyen-Van-Tam JS; Turtle L; Docherty AB; Openshaw PJ; Baillie JK; Harrison EM; Semple MG;
Lancet; 2021 Jul; 398(10296):223-237. PubMed ID: 34274064
[TBL] [Abstract][Full Text] [Related]
7. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.
Docherty AB; Harrison EM; Green CA; Hardwick HE; Pius R; Norman L; Holden KA; Read JM; Dondelinger F; Carson G; Merson L; Lee J; Plotkin D; Sigfrid L; Halpin S; Jackson C; Gamble C; Horby PW; Nguyen-Van-Tam JS; Ho A; Russell CD; Dunning J; Openshaw PJ; Baillie JK; Semple MG;
BMJ; 2020 May; 369():m1985. PubMed ID: 32444460
[TBL] [Abstract][Full Text] [Related]
8. Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort study.
Turtle L; Elliot S; Drake TM; Thorpe M; Khoury EG; Greenhalf W; Hardwick HE; Leeming G; Law A; Oosthuyzen W; Pius R; Shaw CA; Baillie JK; Openshaw PJM; Docherty AB; Semple MG; Harrison EM; Palmieri C;
Lancet Oncol; 2024 May; 25(5):636-648. PubMed ID: 38621404
[TBL] [Abstract][Full Text] [Related]
9. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
10. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study.
Aveyard P; Gao M; Lindson N; Hartmann-Boyce J; Watkinson P; Young D; Coupland CAC; Tan PS; Clift AK; Harrison D; Gould DW; Pavord ID; Hippisley-Cox J
Lancet Respir Med; 2021 Aug; 9(8):909-923. PubMed ID: 33812494
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study.
Gupta RK; Harrison EM; Ho A; Docherty AB; Knight SR; van Smeden M; Abubakar I; Lipman M; Quartagno M; Pius R; Buchan I; Carson G; Drake TM; Dunning J; Fairfield CJ; Gamble C; Green CA; Halpin S; Hardwick HE; Holden KA; Horby PW; Jackson C; Mclean KA; Merson L; Nguyen-Van-Tam JS; Norman L; Olliaro PL; Pritchard MG; Russell CD; Scott-Brown J; Shaw CA; Sheikh A; Solomon T; Sudlow C; Swann OV; Turtle L; Openshaw PJM; Baillie JK; Semple MG; Noursadeghi M;
Lancet Respir Med; 2021 Apr; 9(4):349-359. PubMed ID: 33444539
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.
Knight SR; Ho A; Pius R; Buchan I; Carson G; Drake TM; Dunning J; Fairfield CJ; Gamble C; Green CA; Gupta R; Halpin S; Hardwick HE; Holden KA; Horby PW; Jackson C; Mclean KA; Merson L; Nguyen-Van-Tam JS; Norman L; Noursadeghi M; Olliaro PL; Pritchard MG; Russell CD; Shaw CA; Sheikh A; Solomon T; Sudlow C; Swann OV; Turtle LC; Openshaw PJ; Baillie JK; Semple MG; Docherty AB; Harrison EM;
BMJ; 2020 Sep; 370():m3339. PubMed ID: 32907855
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.
Swann OV; Holden KA; Turtle L; Pollock L; Fairfield CJ; Drake TM; Seth S; Egan C; Hardwick HE; Halpin S; Girvan M; Donohue C; Pritchard M; Patel LB; Ladhani S; Sigfrid L; Sinha IP; Olliaro PL; Nguyen-Van-Tam JS; Horby PW; Merson L; Carson G; Dunning J; Openshaw PJM; Baillie JK; Harrison EM; Docherty AB; Semple MG;
BMJ; 2020 Aug; 370():m3249. PubMed ID: 32960186
[TBL] [Abstract][Full Text] [Related]
14. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
[TBL] [Abstract][Full Text] [Related]
15. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study.
Närhi F; Moonesinghe SR; Shenkin SD; Drake TM; Mulholland RH; Donegan C; Dunning J; Fairfield CJ; Girvan M; Hardwick HE; Ho A; Leeming G; Nguyen-Van-Tam JS; Pius R; Russell CD; Shaw CA; Spencer RG; Turtle L; Openshaw PJM; Baillie JK; Harrison EM; Semple MG; Docherty AB;
Lancet Digit Health; 2022 Apr; 4(4):e220-e234. PubMed ID: 35337642
[TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids for the treatment of COVID-19.
Griesel M; Wagner C; Mikolajewska A; Stegemann M; Fichtner F; Metzendorf MI; Nair AA; Daniel J; Fischer AL; Skoetz N
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD015125. PubMed ID: 35262185
[TBL] [Abstract][Full Text] [Related]
17. Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort study.
Shi T; Pan J; Katikireddi SV; McCowan C; Kerr S; Agrawal U; Shah SA; Simpson CR; Ritchie LD; Robertson C; Sheikh A;
Lancet Respir Med; 2022 Feb; 10(2):191-198. PubMed ID: 34861180
[TBL] [Abstract][Full Text] [Related]
18. Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study.
Shi T; Pan J; Vasileiou E; Robertson C; Sheikh A;
Lancet Respir Med; 2022 Apr; 10(4):347-354. PubMed ID: 35033224
[TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Spencer S; Karner C; Cates CJ; Evans DJ
Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD007033. PubMed ID: 22161409
[TBL] [Abstract][Full Text] [Related]
20. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Spencer S; Evans DJ; Karner C; Cates CJ
Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
